Analysen von Yaron Werber

01.08.12 Dendreon neutral Citigroup Corp.
13.04.12 Dendreon neutral Citigroup Corp.
08.02.12 Amylin Pharmaceuticals neutral Citigroup Corp.
07.12.11 Amylin Pharmaceuticals neutral Citigroup Corp.
31.10.11 Biogen neutral Citigroup Corp.
27.10.11 Human Genome Sciences neutral Citigroup Corp.
19.10.11 Biogen neutral Citigroup Corp.
14.10.11 Regeneron Pharmaceuticals neutral Citigroup Corp.
14.10.11 Biogen neutral Citigroup Corp.
11.10.11 Gilead Sciences neutral Citigroup Corp.
11.10.11 Amylin Pharmaceuticals neutral Citigroup Corp.
06.10.11 Amylin Pharmaceuticals hold Citigroup Corp.
05.10.11 Human Genome Sciences hold Citigroup Corp.
30.08.11 Gilead Sciences hold Citigroup Corp.
30.08.11 Amylin Pharmaceuticals hold Citigroup Corp.
29.08.11 Regeneron Pharmaceuticals hold Citigroup Corp.
24.08.11 Gilead Sciences hold Citigroup Corp.
22.07.11 Human Genome Sciences hold Citigroup Corp.
21.07.11 Human Genome Sciences hold Citigroup Corp.
07.06.11 Amylin Pharmaceuticals hold Citigroup Corp.
17.05.11 Gilead Sciences hold Citigroup Corp.
17.05.11 Amylin Pharmaceuticals hold Citigroup Corp.
20.04.11 Amylin Pharmaceuticals hold Citigroup Corp.
11.01.11 Gilead Sciences hold Citigroup Corp.
11.01.11 Amylin Pharmaceuticals hold Citigroup Corp.
18.11.10 Human Genome Sciences hold Citigroup Corp.